TNFSF14 and glioblastoma: He et al. (2018) found TNFSF14–CGKRK could induce high endothelial venules formation and lymphocyte accumulation in murine glioblastoma (He et al., 2018). Brunetti et al. (2020) found that the expression of TNFSF14 in serum was higher in patients with bone metastases than in controls (Brunetti et al., 2020). TNFSF14 could promote osteolytic bone metastases in non-small cell lung cancer patients (Brunetti et al., 2020).